14 Feb 2017
Over 350 million people worldwide are suffering from rare diseases. Which is why it is necessary to understand the rare disease landscape to date.
21 Total results for product and free and sample content found
23 Nov 2016
See how the value of drugs differentiate therapies by sub-population. Find out where the disproportionate value of your drug lies alongside competitors. Uncover demonstrable differentiated value when entering a crowded market. Discover the power of RxScorecard™.
By Patricia Giglio 14 Nov 2016
Partnering came into use twenty-odd years ago when pharmaceutical companies began working with biotech and increasingly sought external discovery and development opportunities.
By Colin White, Robert Jeng & Jolene Lau 26 Oct 2016
This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well
By Ljlal Syed, Mark Lansdell and David Abramson 20 Oct 2016
This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic
Topic Deal trends
By Steven Muntner 20 Oct 2016
Royalty payments are an essential component of most pharmaceutical deals. Along with upfront payments and milestones, companies are rewarded for surpassing certain developmental hurdles.
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: